Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase

被引:62
作者
Rodríguez-Martínez, JM
Pascual, A
García, I
Martínez-Martínez, L
机构
[1] Univ Seville, Sch Med, Dept Microbiol, E-41009 Seville, Spain
[2] Univ Seville, Univ Hosp Virgen Macarena, Seville, Spain
关键词
Escherichia coli; fluoroquinolones; cephamycinase; molecular epidemiology;
D O I
10.1093/jac/dkg388
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Plasmid pMG252 contains the qnr locus, which is responsible for low-level resistance to quinolones by protecting the DNA gyrase. pMG252 also encodes the AmpC-type beta-lactamase (pACBL), FOX-5. The aim of this study was to determine the prevalence of qnr in strains from different geographical locations in America and Europe. Methods: Four hundred and twenty-five (159 Klebsiella pneumoniae and 266 Escherichia coli) clinical isolates were studied. The detection of qnr was by PCR using specific primers for an internal fragment of 543 bp. Results: qnr was detected in three cefoxitin-resistant K. pneumoniae strains, which also produced a pACBL. None of the E. coli isolates tested contained qnr. The three qnr-positive K. pneumoniae came from the USA, and all transferred a conjugative plasmid coding for cefoxitin resistance to E. coli J53. qnr was also transferred by the same plasmid in two out of the three strains. The sequences of amplified qnr fragments from the three strains were identical to the qnr sequence from pMG252. Conclusions: The qnr determinant is uncommon among clinical isolates of K. pneumoniae and E. coli, but its identification in three pACBL(+) K. pneumoniae from the USA indicates the emergence of this quinolone resistance mechanism.
引用
收藏
页码:703 / 706
页数:4
相关论文
共 14 条
[1]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[2]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002) [J].
Hernández, JR ;
Pascual, A ;
Cantón, R ;
Martinez-Martínez, L .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (02) :77-82
[3]   Emerging mechanisms of fluoroquinolone resistance [J].
Hooper, DC .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :337-341
[4]   Prevalence of plasmid-mediated quinolone resistance [J].
Jacoby, GA ;
Chow, N ;
Waites, KB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :559-562
[5]  
JACOBY GA, 1995, 35 INT C ANT AG CHEM, P46
[6]   Quinolone resistance from a transferable plasmid [J].
Martínez-Martínez, L ;
Pascual, A ;
Jacoby, GA .
LANCET, 1998, 351 (9105) :797-799
[7]   Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production [J].
Martínez-Martínez, L ;
Pascual, A ;
Conejo, MD ;
García, I ;
Joyanes, P ;
Doménech-Sánchez, A ;
Benedí, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3926-3932
[8]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[9]   Plasmid-determined AmpC-type β-lactamases [J].
Philippon, A ;
Arlet, G ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :1-11
[10]   CHARACTERIZATION OF BETA-LACTAMASES INSITU ON POLYACRYLAMIDE GELS [J].
SANDERS, CC ;
SANDERS, WE ;
MOLAND, ES .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :951-952